Hyperspectral imaging for tissue classification, a way toward smart laparoscopic colorectal surgery

Elisabeth J M Baltussen, Esther N D Kok, Susan G Brouwer de Koning, Joyce Sanders, Arend G J Aalbers, Niels F M Kok, Geerard L Beets, Claudie C Flohil, Sjoerd C Bruin, Koert F D Kuhlmann, Henricus J C M Sterenborg, Theo J M Ruers, Elisabeth J M Baltussen, Esther N D Kok, Susan G Brouwer de Koning, Joyce Sanders, Arend G J Aalbers, Niels F M Kok, Geerard L Beets, Claudie C Flohil, Sjoerd C Bruin, Koert F D Kuhlmann, Henricus J C M Sterenborg, Theo J M Ruers

Abstract

In the last decades, laparoscopic surgery has become the gold standard in patients with colorectal cancer. To overcome the drawback of reduced tactile feedback, real-time tissue classification could be of great benefit. In this ex vivo study, hyperspectral imaging (HSI) was used to distinguish tumor tissue from healthy surrounding tissue. A sample of fat, healthy colorectal wall, and tumor tissue was collected per patient and imaged using two hyperspectral cameras, covering the wavelength range from 400 to 1700 nm. The data were randomly divided into a training (75%) and test (25%) set. After feature reduction, a quadratic classifier and support vector machine were used to distinguish the three tissue types. Tissue samples of 32 patients were imaged using both hyperspectral cameras. The accuracy to distinguish the three tissue types using both hyperspectral cameras was 0.88 (STD = 0.13) on the test dataset. When the accuracy was determined per patient, a mean accuracy of 0.93 (STD = 0.12) was obtained on the test dataset. This study shows the potential of using HSI in colorectal cancer surgery for fast tissue classification, which could improve clinical outcome. Future research should be focused on imaging entire colon/rectum specimen and the translation of the technique to an intraoperative setting.

Keywords: colorectal cancer; hyperspectral imaging; machine learning; margin assessment; support vector machine.

Figures

Fig. 1
Fig. 1
(a) Hyperspectral image, with two spatial dimensions (x,y) and one spectral dimension (λ). (b) On the right side, the spectra of the two selected pixels are shown.
Fig. 2
Fig. 2
Registration of the HSI, RGB, and pathology images. In the upper row from left to right, annotated pathology image (yellow = fat, green = healthy colorectal wall, red = tumor, blue = mucosa), RGB image and HSI. The second row from left to right, the annotated pathology image registered to the RGB image and the RGB image registered to the HSI.
Fig. 3
Fig. 3
Spectral bands determined for the dataset with the combination of visual and near-infrared camera images are shown together with the mean spectra of fat (yellow), healthy colorectal wall (green), and tumor (red). The 13 spectral bands all have a different gray value and are separated by black vertical lines. Between 950 and 970 nm, a gap is shown in the data. This region is not covered by the cameras.
Fig. 4
Fig. 4
Classification of the tissue samples of one patient from the test set of the combined data set of the visual and near-infrared camera. In the first column, the RGB image of each tissue sample is shown. The second column shows the registered annotated pathology image (yellow = fat, green = muscle or healthy colorectal wall, red = tumor, blue = mucosa). In the third column, the classification based on the visual and near-infrared spectra is shown projected on the binary mask of the RGB image (yellow = fat, green = muscle of healthy colorectal wall, red = tumor). The first row shows the healthy tissue including fat and healthy colorectal wall. The second row shows the tumor tissue sample. Tissue annotated by the pathologist as mucosa (blue) is not classified and is shown a white in the third column.
Fig. 5
Fig. 5
ROC curves of the training results of the quadratic classifier distinguishing fat from all other tissue types. The three datasets are shown as the visual camera (green), near-infrared camera (red), and the combination of the visual and near-infrared camera (blue).
Fig. 6
Fig. 6
ROC curves of the training results of the SVMs distinguishing tumor from healthy colorectal tissue. The three datasets are shown as the visual camera (green), near-infrared camera (red), and the combination of the visual and near-infrared camera (blue).
Fig. 7
Fig. 7
Classification of the tissue samples of one patient from the test dataset of the combined dataset. In the first column, the RGB image of each tissue sample is shown. The second column shows the registered annotated pathology H&E image (yellow = fat, green = muscle or healthy colorectal wall, red = tumor, blue = mucosa). In the third to fifth column from the classification based on the visual image only, the classification based on the near-infrared image only and the classification based on the combined visual and near-infrared image are shown, respectively, projected on the binary mask of the RGB image (yellow = fat, green = muscle of healthy colorectal wall, red = tumor). From top to bottom, fat, healthy colorectal wall, and tumor tissue are shown. Tissue annotated as mucosa (blue) by the pathologist is not classified and shown as white in the third to fifth column.

References

    1. Ferlay J., et al. , “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” Int. J. Cancer 136(5), E359–E386 (2015).IJCNAW10.1002/ijc.29210
    1. Rabeneck L., et al. , “Cancer: disease control priorities,” in Disease Control Priorities, 3rd ed., pp. 101–119, World Bank, Washington, DC: (2015).
    1. Pascual M., Salvans S., Pera M., “Laparoscopic colorectal surgery: current status and implementation of the latest technological innovations,” World J. Gastroenterol. 22(2), 704–717 (2016).10.3748/wjg.v22.i2.704
    1. Ottermo M. V., et al. , “The role of tactile feedback in laparoscopic surgery,” Surg. Laparosc. Endosc. Percutan. Tech. 16(6), 390–400 (2006).10.1097/01.sle.0000213734.87956.24
    1. Schostek S., Schurr M. O., Buess G. F., “Review on aspects of artificial tactile feedback in laparoscopic surgery,” Med. Eng. Phys. 31(8), 887–898 (2009).MEPHEO10.1016/j.medengphy.2009.06.003
    1. Lu G., Fei B., “Medical hyperspectral imaging: a review,” J. Biomed. Opt. 19(1), 10901 (2014).JBOPFO10.1117/1.JBO.19.1.010901
    1. Benavides J. M., et al. , “Multispectral digital colposcopy for in vivo detection of cervical cancer,” Opt. Express 11(10), 1223–1236 (2003).OPEXFF10.1364/OE.11.001223
    1. Boucheron L. E., et al. , “Utility of multispectral imaging for nuclear classification of routine clinical histopathology imagery,” BMC Cell Biol. 8(Suppl 1), S8–S8 (2007).BCBMAY10.1186/1471-2121-8-S1-S8
    1. Hattery D., et al. , “Hyperspectral imaging of Kaposi’s Sarcoma for disease assessment and treatment monitoring,” in Proc. Appl. Imagery Pattern Recognit. Workshop, pp. 124–130 (2002).10.1109/AIPR.2002.1182265
    1. Liu Z., Wang H., Li Q., “Tongue tumor detection in medical hyperspectral images,” Sensors (Basel) 12(1), 162–174 (2012).10.3390/s120100162
    1. Fei B., et al. , “Label-free reflectance hyperspectral imaging for tumor margin assessment: a pilot study on surgical specimens of cancer patients,” J. Biomed. Opt. 22(8), 086009 (2017).JBOPFO10.1117/1.JBO.22.8.086009
    1. Lu G., et al. , “Detection of head and neck cancer in surgical specimens using quantitative hyperspectral imaging,” Clin. Cancer Res. 23(18), 5426–5436 (2017).10.1158/1078-0432.CCR-17-0906
    1. Akbari H., et al. , “Cancer detection using infrared hyperspectral imaging,” Cancer Sci. 102(4), 852–857 (2011).10.1111/cas.2011.102.issue-4
    1. Kiyotoki S., et al. , “New method for detection of gastric cancer by hyperspectral imaging: a pilot study,” J. Biomed. Opt. 18, 26010–26017 (2013).JBOPFO10.1117/1.JBO.18.2.026010
    1. Masood K., Rajpoot N. M., Nasir M., “Spatial analysis for colon biopsy classification from hyperspectral imagery,” 2008, (23 January 2018).
    1. Masood K., Rajpoot N. M., Nasir M., “Classification of colon biopsy samples by spatial analysis of a single spectral band from its hyperspectral cube,” 2007, (23 January 2018).
    1. Rajpoot K., Rajpoot N., “SVM optimization for hyperspectral colon tissue cell classification,” Lect. Notes Comput. Sci. 3217, 829–837 (2004).LNCSD910.1007/b100270
    1. Rathore S., et al. , “A recent survey on colon cancer detection techniques,” IEEE/ACM Trans. Comput. Biol. Bioinf. 10(3), 545–563 (2013).ITCBCY10.1109/TCBB.2013.84
    1. Maggioni M., et al. , “Hyperspectral microscopic analysis of normal, benign and carcinoma microarray tissue sections,” Proc. SPIE 6091, 60910I (2006).PSISDG10.1117/12.646078
    1. Claridge E., Hidović-Rowe D., “Model based inversion for deriving maps of histological parameters characteristic of cancer from ex-vivo multispectral images of the colon,” IEEE Trans. Med. Imaging 33(4), 822–835 (2014).ITMID410.1109/TMI.2013.2290697
    1. Han Z., et al. , “In vivo use of hyperspectral imaging to develop a noncontact endoscopic diagnosis support system for malignant colorectal tumors,” Proc. SPIE 21(1), 016001 (2016).PSISDG10.1117/1.JBO.21.1.016001
    1. Kumashiro R., et al. , “Integrated endoscopic system based on optical imaging and hyperspectral data analysis for colorectal cancer detection,” Anticancer Res. 36(8), 3925–3932 (2016).ANTRD4
    1. Ocean Optics, “OOINLCorrect loading non-linearity correction coefficients instructions,” Dunedin, 2012, .
    1. Burger J., Geladi P., “Hyperspectral NIR image regression part I: calibration and correction,” J. Chemom. 19(5–7), 355–363 (2005).JOCHEU10.1002/cem.938
    1. Rinnan Å., van den Berg F., Engelsen S. B., “Review of the most common pre-processing techniques for near-infrared spectra,” TrAC Trends Anal. Chem. 28(10), 1201–1222 (2009).10.1016/j.trac.2009.07.007
    1. Baltussen E. J. M., et al. , “Diffuse reflectance spectroscopy as a tool for real-time tissue assessment during colorectal cancer surgery,” J. Biomed. Opt. 22, 106014 (2017).JBOPFO10.1117/1.JBO.22.10.106014
    1. Boughorbel S., Jarray F., El-Anbari M., “Optimal classifier for imbalanced data using Matthews correlation coefficient metric,” PLoS One 12(6), e0177678 (2017).POLNCL10.1371/journal.pone.0177678
    1. Bydlon T. M., et al. , “Chromophore based analyses of steady-state diffuse reflectance spectroscopy: current status and perspectives for clinical adoption,” J Biophotonics 8(1–2), 9–24 (2015).10.1002/jbio.201300198
    1. Spliethoff J. W., et al. , “Real-time in vivo tissue characterization with diffuse reflectance spectroscopy during transthoracic lung biopsy: a clinical feasibility study,” Clin Cancer Res. 22(2), 357–365 (2016).10.1158/1078-0432.CCR-15-0807

Source: PubMed

3
購読する